Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,903,301
+$961,751 QoQ
Shares Held
5,256
+96.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,298
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. AMGN ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
This page
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,903,301 | 5,256 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $941,550 | 2,676 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $873,262 | 2,668 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $59,826 | 212 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $726,225 | 2,601 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $805,668 | 2,586 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $644,302 | 2,472 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $782,648 | 2,429 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $754,879 | 2,416 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $613,278 | 2,157 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $618,378 | 2,147 | Shares | Sole | 2024-04-25 | |
| 2023-09-30 | $616,804 | 2,295 | Shares | Sole | 2024-04-25 | |
| 2023-06-30 | $702,471 | 3,164 | Shares | Sole | 2024-04-25 | |
| 2023-03-31 | $761,754 | 3,151 | Shares | Sole | 2024-04-25 | |
| 2022-12-31 | $827,316 | 3,150 | Shares | Sole | 2024-04-25 | |
| 2022-09-30 | $707,981 | 3,141 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $762,745 | 3,135 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $756,412 | 3,128 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $643,189 | 2,859 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,042,410 | 4,902 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $694,443 | 2,849 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $707,615 | 2,844 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $653,202 | 2,841 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $778,746 | 3,064 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $626,444 | 2,656 | Shares | Sole | 2021-11-02 | |
| 2020-03-31 | $619,745 | 3,057 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||